랩지노믹스

084650KOSDAQ

53.1 / 100

Reference Date: 2026-09-08

Financial Score21.5 / 40

News Sentiment19.6 / 25

Momentum2.0 / 20

Disclosure10.0 / 15

AI Analysis: the debt ratio is very low with excellent financial health but ROE is below the industry average. Plunged 43.3% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

Labgenomics specializes in genetic molecular diagnostics, including non-invasive prenatal testing (NIPT), cancer gene screening, and chromosomal abnormality detection. As the first company in South Korea to commercialize NIPT, it leads the market with its 'MomGuard' product line and continues to expand its portfolio with innovations like the LabGun COVID-19 assay and early Alzheimer's diagnostic kits.

Number of Employees

142people

Average Salary

49.7M KRW

Score Calculation Basis

Detailed Financial Score

PER

—Industry Average 15.004.0Point

PBR

0.25Industry Average 1.207.0Point

Half of industry avg (excellent)

ROE

-35.18Industry Average 8.000.0Point

Well below industry avg

Debt Ratio

13.61Industry Average 100.008.0Point

Half of industry avg (excellent)

Trend 2023~20252.5 / 10 points

Revenue Growth Rate

2.5 / 3

Avg ▲10.0% (2-year basis)

Operating Profit Growth Rate

0.0 / 3

Avg ▼180.8% (2-year basis)

ROE Trend

0.0 / 4

Avg ROE -16.1% (declining, 3yr)

Detailed News Sentiment

3 totalPositive 2Neutral 0Negative 1Average Sentiment Score 78.3

Negative
[단독][기로의상장사]랩지노믹스①'사무장병원' 운영 혐의로 압수수색.....
랩지노믹스는 사무장병원 운영 혐의로 압수수색을 받아 주가에 부정적 영향을 받고 있다.
Positive
랩지노믹스, 5대1 주식병합…다음달 23일 신주 상장
랩지노믹스의 주식 액면병합 결정으로 주주 가치 증대 기대.
Positive
랩지노믹스 "완결형 진단으로 美혈액암 시장공략"
랩지노믹스가 미국 액체생검 기업과의 라이선스 계약을 통해 미국 혈액암 시장 진출을 확대할 계획으로 긍정적인 성장 전망을 보임.

Detailed Momentum

52-week position1.0Point

Near 52w low (0%, downtrend)

Current 500Won52-week high 2,50552-week low 500

1-month return0.0Point

1m -43.31% (strong drop)

Volume trend1.0Point

Volume dry-up

Detailed Disclosure

7 totalPositive 0Neutral 7Negative 0

Neutral주권매매거래정지 (주식의 병합, 분할 등 전자등록 변경, 말소)2026-08-27
Neutral전환가액의조정 (제5회차)2026-08-20
Neutral독립이사의선임ㆍ해임또는중도퇴임에관한신고2026-08-18
Neutral임시주주총회결과2026-08-18
Neutral반기보고서 (2026.06)2026-08-14